Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. JOHMPE [інтернет]. 27, Лютий 2025 [цит. за 25, Серпень 2026];3(1). доступний у: https://shmpublisher.com/index.php/johmpe/article/view/547